2 Suppliers
1 Customers
3 Debt Items
20 Related Chains
Search FHTX in the supply chain database
Create FHTX supply chain alerts
Read FHTX supply chain intel
ORANGE supply chain
NVIDIA Corporation supply chain
Amazon.com, Inc. supply chain
Johnson & Johnson supply chain
Suppliers 2
Clients 1
Debt 3
Acquisitions 0
Ownership 1
Secondary 20
Foghorn Therapeutics Inc. Suppliers
Ticker Name Confidence Evidence
LLY
Eli Lilly and Company
90%
Concurrent with the Lilly Collaboration Agreement, we also entered into a stock purchase agreement (the "Lilly SPA") with Lilly whereby we issued and sold Lilly 4,000,000 shares of our common stock, …
LLY
Eli Lilly and Company
90%
Reciprocal relationship from LLY graph: Reciprocal relationship from FHTX graph: Concurrent with the Lilly Collaboration Agreement, we also entered into a stock purchase agreement (the "Lilly SPA") w…
Foghorn Therapeutics Inc. Customers
Ticker Name Confidence Evidence
LILLY
LILLY
92%
Lilly is a leading oncology company with a track record of innovation and execution
Foghorn Therapeutics Inc. Debt Obligations
Instrument Description Confidence Evidence
FHTX-DEBT-9496
Warrants outstanding: 114000
90%
xbrl warrant detail from xbrl 2021-12-31.
FHTX-DEBT-9497
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
FHTX-DEBT
Debt stack $42.0M
90%
Market cache reports total debt of $42.0M.
Foghorn Therapeutics Inc. Acquisitions
No acquisitions on record No completed or pending acquisitions found in our database for Foghorn Therapeutics Inc..
Foghorn Therapeutics Inc. Ownership
Holder Name Confidence Evidence
FHTX-OWNER-FLAGSHIP-PIONEERING-LLC
Flagship Pioneering, LLC
90%
13F overlay lists Flagship Pioneering, LLC as top holder; 105 tracked holders.
Foghorn Therapeutics Inc. Extended Supply Chain Network
Ticker Name Chain Index Hops Relationship Types
CRIS
Curis, Inc.
100.00
2
IMNM
Immunome, Inc.
100.00
2
ACIU
AC Immune SA
100.00
2
FDMT
4D Molecular Therapeutics, Inc.
100.00
2
VEEV
Veeva Systems Inc.
100.00
2
VNDA
Vanda Pharmaceuticals Inc.
100.00
2
DAWN
Day One Biopharmaceuticals Inc
100.00
2
BYSI
BeyondSpring Inc.
100.00
2
ACRS
Aclaris Therapeutics, Inc.
100.00
2
AXSM
Axsome Therapeutics, Inc.
100.00
2
BIOA
BioAge Labs, Inc.
100.00
2
ALEC
Alector, Inc.
100.00
2
CTNM
Contineum Therapeutics, Inc.
100.00
2
NVO
Novo Nordisk A/S
100.00
2
DSGN
Design Therapeutics, Inc.
100.00
2
SDGR
Schrödinger, Inc.
100.00
2
ALNY
Alnylam Pharmaceuticals, Inc.
100.00
2
AKTS
Aktis Oncology, Inc.
100.00
2
EDSA
Edesa Biotech, Inc.
100.00
2
VIVS
VivoSim Labs, Inc.
100.00
2